The renin-angiotensin system in the endocrine pancreas

Journal of the Pancreas

Volumn 2, Issue 1, 2001, Pages 26-32

  Carlsson, Per Ola ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Angiotensin II. Insulin (secretion); Islets of Langerhans; Microcirculation

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILATE; INSULIN; RAMIPRIL; RENIN; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; DIABETES MELLITUS; ENDOCRINE FUNCTION; HORMONE ACTION; HUMAN; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; NONHUMAN; PANCREAS FUNCTION; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TISSUE DISTRIBUTION; ANIMAL; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; DIABETES MELLITUS; HUMANS; ISLETS OF LANGERHANS; RENIN-ANGIOTENSIN SYSTEM;

EID: 0035239910     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Vallottori MB. The renin-angiotensin system. Trends Pharmacol Sci 1987; 8:69-74.
2. Suvannapura A, Levens NR. Local control of mesenteric blood flow by the renin-angiotensin system. Am J Physiol 1988; 255:G267-74.
3. Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 1986; 78:31-9.
4. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest 1987; 79:1-6.
5. Dzau VJ, Kristin EE, Brody T, Ingelfinger J, Pratt RE. A comparative study of the distributions of renin and angiotensinogen messenger ribonucleic acids in rat and in mouse and in rat tissues. Endocrinology 1987; 120:2334-8.
6. Vinson GP, Saridogan E, Puddefoot JR, Djahanbakhch O. Tissue renin-angiotensin systems and reproduction. Hum Reprod 1997; 12:651-62. [97302988]
7. Phillips MI, Speakman EA, Kimura B. Levels of angiotensin and molecular biology of the tissue renin-angiotensin systems. Regul Pept 1993; 43:1-20. [93150166]
8. Wang Y, Yamaguchi T, Francosaenz R, Mulrow PJ. Regulation of renin gene expression in rat adrenal zona glomerulosa cells. Hypertension 1992; 20:766-81.
9. Chappell MC, Millsted A, Diz DI, Brosnihan KB, Ferrario CM. Evidence for an intrinsic angiotensin system in the canine pancreas. J Hypertension 1991; 9:751-9. [92012988]
10. Ghiani BU, Masini MA. Angiotensin II binding sites in the rat pancreas and their modulation after sodium loading and depletion. Comp Biochem Physiol A Physiol 1995; 111:439-44. [95338780]
11. Leung PS, Chan WP, Wong TP, Sernia C. Expression and localization of the renin-angiotensin system in the rat pancreas. J Endocrinol 1999; 160:13-9. [99077887]
12. Tahmasebi M, Puddefoot JR, Inwang ER, Vinson GP. The tissue renin-angiotensin system in human pancreas. J Endocrinol 1999; 161:317-22. [99271012]
13. Hata A. Role of angiotensinogen in the genetics of essential hypertension. Life Sci 1995; 57:2385-95.
14. National High Blood Pressure Education Program Working Group report on hypertension in diabetes. Hypertension 1994; 23:145-58. [94140428]
15. Stern MP. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 1995; 44:369-74.
16. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321:868-73.
17. Hänni A, Andersson PE, Lind L, Berne C, Lithell H. Electrolyte changes and metabolic effects of lisinopril/bendrofluazide treatment. Results from a randomised, double-blind study with parallel groups. Am J Hypertension 1994; 7:615-22.
18. Santoro D, Natali A, Palombo C, Brandi LS, Piatti M, Ghione S, Ferrannini E. Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypeertension. Hypertension 1992; 20:181-91.
19. Reid IA, Morris BJ, Ganong WF. The renin-angiotensin system. Ann Rev Physiol 1978; 40:377-410.
20. Brasier AE, Philippe J, Campbell DJ, Habener JF. Novel expression of the angiotensinogen gene in a rat pancreatic islet cell line. J Biol Chem 1986; 261:16148-54. [87057283]
21. Philippe J, Drucker DJ, Chick WL, Habener JF. Transcriptional regulation of genes encoding insulin, glucagon and angiotensinogen by sodium butyrate in a rat islet cell line. Mol Cell Biol 1987; 7:560-3.
22. Hojima Y, Yamashita N, Ochi N, Moriwaki C, Moriya H. Isolation and properies of dog and rat pancreatic kallikreins. J Biochem 1977; 81:599-610.
23. Arakawa K, Maruta H. Ability of kallikrein to generate angiotensin II-like pressor substance and a proposed kinin-tensin enzyme system. Nature 1980; 288:705-6. [81098953]
24. Arakawa K. Serine protease angiotensin II systems. J Hypertension 1996; 14 (Suppl): S3-7.
25. Sasaguri M, Noda K, Tsuji E, Koga M, Kinoshita A, Ideishi M, et al. Structure of a kallikrein-like enzyme and its tissue localization in the dog. Immunopharmacology 1999; 44:15-9.
26. Dzau VJ, Burt DW, Pratt RE. Moelcular biology of the renin-angiotensin system. Am J Physiol 1988; 255:F563-73.
27. Leung PS, Chan HC, Wong PYD. Immunohistochemical localization of angiotensin II in the mouse pancreas. Histochem J 1998; 30:21-5. [98198607]
28. Chappell MC, Diz DI, Jacobsen DW. Pharmacological characterization of angiotensin II binding sites in the canine pancreas. Peptides 1992; 13:313-8. [93027675]
29. 2 in the pancreas of rodents. J Endocrinol 1997; 153:269-74. [97308925]
30. Jaiswal N, Diz DI, Tallant EA, Khosla MC, Ferrario CM. Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells. Am J Physiol 1991; 260:R1000-6.
31. Jaiswal N, Taillant EA, Diz DI, Khosla MC, Ferrario CM. Identification of two distinct angiotensin receptors on human astrocytes using an angiotensin receptor antagonist. Hypertension 1990; 17:1115-20.
32. Kelly KL, Laychock SG. Prostaglandin synthesis and metabolism in isolated pancreatic islets of the rat. Prostaglandinds 1981; 21:756-69.
33. Dunning BE, Moltz JH, Fawcett CP. Actions of neurohypophysial peptides on pancreatic hormone release. Am J Physiol 1984; 246:E108-14.
34. Carlsson PO, Berne C, Jansson L. Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 1998; 41:127-33. [98158409]
35. Gardiner SM, Kemp PA, March JE, Bennett T. Regional haemodynamic effects of angiotensin II (3-8) in conscious rats. Br J Pharmacol 1993; 110:159-62.
36. Ray-Chauduri K, Thomaides T, Maule S, Watson L, Lowe S, Mathias CJ. The effect of captopril on the superior mesenteric artery and portal venous blood flow in normal man. Br J Clin Pharmacol 1993; 35:517-24.
37. Fliser D, Schaefer F, Schmid D, Veldhuis JD, Ritz E. Angiotensin II affects basal, pulsatile and glucose-stimulated insulin secretion in humans. Hypertension 1997; 30:1156-61.
38. Olsson R, Jansson L, Andersson A, Carlsson PO. Local blood flow regulation in transplanted rat pancreatic islets: influence of adenosine, angiotensin II and nitric oxide inhibition. Transplantation 2000; 70:280-7.
39. Carlsson PO, Liss P, Andersson A, Jansson L. Measurements of oxygen tension in native and transplanted rat pancreatic islets. Diabetes 1998; 47:1027-32.
40. Carlsson PO, Palm F, Andersson A, Liss P. Chronically decreased oxygen tension in rat pancreatic islets transplanted under the kidney capsule. Transplantation 2000; 69:761-6.
41. Chan WP, Fung LM, Nobiling R, Leung PS. Activation of local renin-angiotensin system by chronic hypoxia in rat pancreas. Mol Cell Endocrinol 2000; 160:107-14. [20181765]
42. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting enzyme inhibitor ramipril on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study. N Engl J Med 2000; 342:145-53. [20092358]
43. Hansson L, Lindholm DH, Niskanen L, Lanke J, Hedner T, Niklason A. Effects of angiotensinconverting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomised trial. Lancet 1999; 353:611-6.
44. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317:350-7.
45. Hellerström C. The life story of the pancreatic B cell. Diabetologia 1984; 26:393-400.
46. Jandeleit K, Rumble J, Jackson B, Cooper ME. Mesenteric vascular angiotensin-converting enzyme is increased in experimental diabetes mellitus. Clin Exp Pharmacol Physiol 1992; 19:343-7.
47. Christlieb AR, Janka HU, Kraus B, Gleason RE, Icasas-Cabral EA, Aiello LM. Vascular reactivity to angiotensin II and norepinephrine in diabetic subjects. Diabetes 1976; 25:268-74.
48. Drury PL, Smith GM, Ferris JB. Increased vasopressor responsiveness to angiotensin II in Type 1 (insulin-dependent) diabetic patients without complications. Diabetologia 1984; 27:174-9.
49. Jandeleit K, Jackson B, Perich R, Paxton D, Johnston CI. Angiotensin-converting enzyme in macroand microvessels of the rat. Clin Exp Pharmacol Physiol 1991; 18:353-6.
50. Rozsa Z, Sonkodi S. The effect of long-term oral captopril treatment on mesenteric blood flow in spontaneously hypertensive rats. Pharmacol Res 1995; 32:21-5.